Showing 1 - 10 results of 10 for search 'Evelyn Hogg', query time: 0.04s
Refine Results
-
1
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. by Andrew Zolopa, Janet Andersen, William Powderly, Alejandro Sanchez, Ian Sanne, Carol Suckow, Evelyn Hogg, Lauren Komarow
Published 2009-01-01
Article -
2
Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells by Fred Richard Sattler, Daniel Chelliah, Xingye Wu, Alejandro Sanchez, Michelle A. Kendall, Evelyn Hogg, David Lagat, Umesh Lalloo, Valdilea Veloso, Diane V. Havlir, Alan Landay
Published 2018-04-01
Article -
3
Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. by Philip M Grant, Lauren Komarow, Janet Andersen, Irini Sereti, Savita Pahwa, Michael M Lederman, Joseph Eron, Ian Sanne, William Powderly, Evelyn Hogg, Carol Suckow, Andrew Zolopa
Published 2010-07-01
Article -
4
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistanc... by Robert A. Salata, Beatriz Grinsztejn, Justin Ritz, Ann C. Collier, Evelyn Hogg, Robert Gross, Catherine Godfrey, Nagalingeswaran Kumarasamy, Cecilia Kanyama, John W. Mellors, Carole L. Wallis, Michael D. Hughes, the ACTG A5288 Study Team
Published 2023-01-01
Article -
5
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)—report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerab... by Umesh G. Lalloo, Lauren Komarow, Judith A. Aberg, David B. Clifford, Evelyn Hogg, Ashley McKhann, Aggrey Bukuru, David Lagat, Sandy Pillay, Vidya Mave, Khuanchai Supparatpinyo, Wadzanai Samaneka, Deborah Langat, Eduardo Ticona, Sharlaa Badal-Faesen, Robert A. Larsen
Published 2023-01-01
Article -
6
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. by Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, Christina M Lalama, Joshua C Cyktor, Bernard J Macatangay, Charles R Rinaldo, Sharon A Riddler, Evelyn Hogg, Catherine Godfrey, Ann C Collier, Joseph J Eron, John W Mellors, ACTG A5321 Team
Published 2017-04-01
Article -
7
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerab... by Umesh G Lalloo, Lauren Komarow, Judith A Aberg, David B Clifford, Evelyn Hogg, Ashley McKhann, Aggrey Bukuru, David Lagat, Sandy Pillay, Vidya Mave, Khuanchai Supparatpinyo, Wadzanai Samaneka, Deborah Langat, Eduardo Ticona, Sharlaa Badal-Faesen, Robert A Larsen, ACTG A5225 Team
Published 2023-01-01
Article -
8
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial by Andreas Diacon, ProfPhD, Sachiko Miyahara, PhD, Rodney Dawson, PhD, Xin Sun, PhD, Evelyn Hogg, Kathleen Donahue, MA, Michael Urbanowski, PhD, Veronique De Jager, MD, Courtney V Fletcher, ProfPharmD, Richard Hafner, MD, Susan Swindells, ProfMBBS, William Bishai, ProfMD
Published 2020-06-01
Article -
9
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. by Shahin Lockman, Michael Hughes, Fred Sawe, Yu Zheng, James McIntyre, Tsungai Chipato, Aida Asmelash, Mohammed Rassool, Sylvester Kimaiyo, Douglas Shaffer, Mina Hosseinipour, Lerato Mohapi, Francis Ssali, Margret Chibowa, Farida Amod, Elias Halvas, Evelyn Hogg, Beverly Alston-Smith, Laura Smith, Robert Schooley, John Mellors, Judith Currier, OCTANE (Optimal Combination Therapy After Nevirapine Exposure) ACTG A5208/OCTANE Study Team
Published 2012-01-01
Article -
10
Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial by Robert Gross, MD MSCE, Justin Ritz, MS, Michael D Hughes, ProfPhD, Robert Salata, ProfMD, Peter Mugyenyi, ProfFRCPE, Evelyn Hogg, BA, Linda Wieclaw, BA, Catherine Godfrey, MD, Carole L Wallis, PhD, John W Mellors, ProfMD, Victor O Mudhune, MPH, Sharlaa Badal-Faesen, MBBCh, Beatriz Grinsztejn, ProfMD, Ann C Collier, ProfMD
Published 2019-05-01
Article